AngioDynamics Shares Surge on Strong Earnings and Insider Confidence
11.10.2025 - 06:36:03
Medical technology company AngioDynamics is experiencing substantial momentum following the release of its quarterly financial results, which significantly surpassed market expectations. The positive performance has triggered analyst upgrades and a notable display of confidence from the company’s leadership.
For the first quarter of fiscal year 2026, AngioDynamics reported revenue of $75.7 million, comfortably exceeding the $72.7 million forecast. This represents a 12.2 percent increase in net sales compared to the same period last year. The company also outperformed expectations on adjusted earnings per share, reporting a loss of $0.10 per share versus the anticipated loss of $0.12 per share.
The Med Tech division demonstrated particularly strong growth, with revenues surging 26.1 percent year-over-year. Meanwhile, the Med Device segment posted a more moderate 2.3 percent gain. Overall gross... Read more...
